Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Interpace Biosciences stock

Learn how to easily invest in Interpace Biosciences stock.

Interpace Biosciences Inc is a diagnostics & research business based in the US. Interpace Biosciences shares (IDXG) are listed on the OTCQX (a marketplace for buying and selling "over the counter" stocks which aren't listed on a formal stock exchange) and all prices are listed in US Dollars. Interpace Biosciences employs 147 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Interpace Biosciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IDXG – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Interpace Biosciences stock price (OTCQX: IDXG)

Use our graph to track the performance of IDXG stocks over time.

Interpace Biosciences shares at a glance

Information last updated 2022-07-01.
Latest market close$3.20
52-week range$2.76 - $10.50
50-day moving average $3.54
200-day moving average $5.91
Wall St. target price$11.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.12

Buy Interpace Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Interpace Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Interpace Biosciences price performance over time

Historical closes compared with the close of $3.2 from 2022-07-01

1 week (2022-06-28) -4.48%
1 month (2022-06-06) -11.11%
3 months (2022-04-06) -36.00%
6 months (2022-01-06) -62.35%
1 year (2021-07-06) -68.63%
2 years (2020-07-06) -49.69%
3 years (2019-07-05) 350.70%
5 years (2017-07-05) 232.54%

Interpace Biosciences financials

Revenue TTM $41.9 million
Gross profit TTM $17.9 million
Return on assets TTM -16.91%
Return on equity TTM -161.49%
Profit margin -31.02%
Book value $0.42
Market capitalisation $14.5 million

TTM: trailing 12 months

Interpace Biosciences share dividends

We're not expecting Interpace Biosciences to pay a dividend over the next 12 months.

Have Interpace Biosciences's shares ever split?

Interpace Biosciences's shares were split on a 1:10 basis on 14 January 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Interpace Biosciences shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Interpace Biosciences shares which in turn could have impacted Interpace Biosciences's share price.

Interpace Biosciences share price volatility

Over the last 12 months, Interpace Biosciences's shares have ranged in value from as little as $2.755 up to $10.5. A popular way to gauge a stock's volatility is its "beta".

IDXG.US volatility(beta: 1.29)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (OTCQX average) beta is 1, while Interpace Biosciences's is 1.2872. This would suggest that Interpace Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Interpace Biosciences overview

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited number of factors; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc.

Frequently asked questions

What percentage of Interpace Biosciences is owned by insiders or institutions?
Currently 27.114% of Interpace Biosciences shares are held by insiders and 0.007% by institutions.
How many people work for Interpace Biosciences?
Latest data suggests 147 work at Interpace Biosciences.
When does the fiscal year end for Interpace Biosciences?
Interpace Biosciences's fiscal year ends in December.
Where is Interpace Biosciences based?
Interpace Biosciences's address is: Morris Corporate Center 1, Parsippany, NJ, United States, 07054
What is Interpace Biosciences's ISIN number?
Interpace Biosciences's international securities identification number is: US46062X3035
What is Interpace Biosciences's CUSIP number?
Interpace Biosciences's Committee on Uniform Securities Identification Procedures number is: 46062X105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site